The present study describes the identification of the Spike protein epitopes of the SARS-CoV-2 variants that are able to generate antisera that inhibit RBD binding to ACE2 and pseudo-virus infection via the hACE2 pathway. Here, ACE2 is linked to viral infectious disease.